4/7
10:03 am
ngne
Neurogene Inc. (NASDAQ: NGNE) was given a new $38.00 price target on by analysts at Robert W. Baird.
Low
Report
Neurogene Inc. (NASDAQ: NGNE) was given a new $38.00 price target on by analysts at Robert W. Baird.
4/2
04:17 pm
ngne
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome [Yahoo! Finance]
High
Report
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome [Yahoo! Finance]
4/2
04:01 pm
ngne
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
Medium
Report
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
3/25
12:18 pm
ngne
Neurogene Inc. (NASDAQ: NGNE) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Neurogene Inc. (NASDAQ: NGNE) had its "outperform" rating re-affirmed by analysts at William Blair.
3/25
08:17 am
ngne
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at HC Wainwright from $55.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at HC Wainwright from $55.00 to $50.00. They now have a "buy" rating on the stock.
3/24
04:26 pm
ngne
Neurogene Inc. (NGNE) Stock [Seeking Alpha]
Low
Report
Neurogene Inc. (NGNE) Stock [Seeking Alpha]
3/24
04:19 pm
ngne
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates [Yahoo! Finance]
Low
Report
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates [Yahoo! Finance]
3/24
04:10 pm
ngne
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
Low
Report
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
11/18/2024
05:25 pm
NGNE
neurogene inc.
BEAT
Report
-13.8%
neurogene inc.
8/9/2024
07:30 am
NGNE
neurogene inc.
MISS
Report
-1.2%
neurogene inc.
5/10/2024
07:30 am
NGNE
neurogene inc.
BEAT
Report
-2.1%
neurogene inc.
4/7
06:01 am
ngne
Form EFFECT Neurogene Inc.
High
Report
Form EFFECT Neurogene Inc.
4/1
05:22 pm
ngne
Form 424B3 Neurogene Inc.
Medium
Report
Form 424B3 Neurogene Inc.
3/31
06:03 am
ngne
Form EFFECT Neurogene Inc.
Medium
Report
Form EFFECT Neurogene Inc.
3/28
09:30 pm
ngne
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cvijic Christine Mikail
High
Report
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cvijic Christine Mikail
3/28
09:30 pm
ngne
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cobb Stuart
High
Report
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cobb Stuart
3/28
09:28 pm
ngne
Form 4 Neurogene Inc. For: Mar 26 Filed by: McMinn Rachel
High
Report
Form 4 Neurogene Inc. For: Mar 26 Filed by: McMinn Rachel
3/28
09:28 pm
ngne
Form 4 Neurogene Inc. For: Mar 26 Filed by: Jordan Julie
High
Report
Form 4 Neurogene Inc. For: Mar 26 Filed by: Jordan Julie
3/24
04:35 pm
ngne
Form S-3 Neurogene Inc.
Low
Report
Form S-3 Neurogene Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register